Early region 1 transforming functions are dispensable for mammary tumorigenesis by human adenovirus type 9.
| Publication Type | Academic Article |
| Authors | Thomas D, Shin S, Jiang B, Vogel H, Ross M, Kaplitt M, Shenk T, Javier R |
| Journal | J Virol |
| Volume | 73 |
| Issue | 4 |
| Pagination | 3071-9 |
| Date Published | 04/01/1999 |
| ISSN | 0022-538X |
| Keywords | Adenovirus E1 Proteins, Adenoviruses, Human, Cell Transformation, Neoplastic, Mammary Neoplasms, Experimental |
| Abstract | Some human adenoviruses are tumorigenic in rodents. Subgroup A and B human adenoviruses generally induce sarcomas in both male and female animals, and the gene products encoded within viral early region 1 (E1 region) are both necessary and sufficient for this tumorigenicity. In contrast, subgroup D human adenovirus type 9 (Ad9) induces estrogen-dependent mammary tumors in female rats and requires the E4 region-encoded ORF1 oncoprotein for its tumorigenicity. Considering the established importance of the viral E1 region for tumorigenesis by adenoviruses, we investigated whether this viral transcription unit is also necessary for Ad9 to generate mammary tumors. The nucleotide sequence of the Ad9 E1 region indicated that the gene organization and predicted E1A and E1B polypeptides of Ad9 are closely related to those of other human adenovirus E1 regions. In addition, an Ad9 E1 region plasmid demonstrated focus-forming activity in both low-passage-number and established rat embryo fibroblasts, whereas a large deletion within either the E1A or E1B gene of this plasmid diminished transforming activity. Surprisingly, we found that introducing the same transformation-inactivating E1A and E1B deletions into Ad9 results in mutant viruses that retain the ability to elicit mammary tumors in rats. These results are novel in showing that Ad9 represents a unique oncogenic adenovirus in which the E4 region, rather than the E1 region, encodes the major oncogenic determinant in the rat. |
| DOI | 10.1128/JVI.73.4.3071-3079.1999 |
| PubMed ID | 10074157 |
| PubMed Central ID | PMC104067 |